# OnCo record kln-1010 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/kln-1010/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "kln-1010" ;
  schema:name "KLN-1010"@en ;
  schema:description "KLN-1010 is an experimental in vivo CAR-T gene therapy from Kelonia Therapeutics, in phase 1 trials for relapsed and refractory multiple myeloma."@en ;
  schema:url <https://onco.cc/drugs/kln-1010/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://keloniatx.com/pipeline/>, <https://www.pharmalive.com/lilly-to-acquire-kelonia-therapeutics-to-advance-in-vivo-car-t-cell-therapies/>, <https://keloniatx.com/>, <https://clinicaltrials.gov/study/NCT07075185>, <https://clinicaltrials.gov/search?intr=KLN-1010> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "In vivo CAR-T gene therapy (lentiviral-based iGPS particles, one-time intravenous dose)" ;
  onco:cancers <https://onco.cc/cancers/myeloma-relapsed-refractory/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:companies <https://onco.cc/companies/kelonia-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07075185/> .